351 related articles for article (PubMed ID: 14745920)
1. Malformations following methimazole exposure in utero: an open issue.
Ferraris S; Valenzise M; Lerone M; Divizia MT; Rosaia L; Blaid D; Nemelka O; Ferrero GB; Silengo M
Birth Defects Res A Clin Mol Teratol; 2003 Dec; 67(12):989-92. PubMed ID: 14745920
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole.
Mujtaba Q; Burrow GN
Obstet Gynecol; 1975 Sep; 46(3):282-6. PubMed ID: 51489
[TBL] [Abstract][Full Text] [Related]
3. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.
Andersen SL; Olsen J; Wu CS; Laurberg P
J Clin Endocrinol Metab; 2013 Nov; 98(11):4373-81. PubMed ID: 24151287
[TBL] [Abstract][Full Text] [Related]
4. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome in women treated with methimazole or propylthiouracil during pregnancy.
Gianetti E; Russo L; Orlandi F; Chiovato L; Giusti M; Benvenga S; Moleti M; Vermiglio F; Macchia PE; Vitale M; Regalbuto C; Centanni M; Martino E; Vitti P; Tonacchera M
J Endocrinol Invest; 2015 Sep; 38(9):977-85. PubMed ID: 25840794
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of hypo- and hyperthyroidism in pregnancy].
Lind P
Acta Med Austriaca; 1997; 24(4):157-8. PubMed ID: 9441554
[TBL] [Abstract][Full Text] [Related]
7. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation.
Yoshihara A; Noh J; Yamaguchi T; Ohye H; Sato S; Sekiya K; Kosuga Y; Suzuki M; Matsumoto M; Kunii Y; Watanabe N; Mukasa K; Ito K; Ito K
J Clin Endocrinol Metab; 2012 Jul; 97(7):2396-403. PubMed ID: 22547422
[TBL] [Abstract][Full Text] [Related]
8. Substituting Potassium Iodide for Methimazole as the Treatment for Graves' Disease During the First Trimester May Reduce the Incidence of Congenital Anomalies: A Retrospective Study at a Single Medical Institution in Japan.
Yoshihara A; Noh JY; Watanabe N; Mukasa K; Ohye H; Suzuki M; Matsumoto M; Kunii Y; Suzuki N; Kameda T; Iwaku K; Kobayashi S; Sugino K; Ito K
Thyroid; 2015 Oct; 25(10):1155-61. PubMed ID: 26222916
[TBL] [Abstract][Full Text] [Related]
9. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
Hackmon R; Blichowski M; Koren G
J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
[TBL] [Abstract][Full Text] [Related]
10. Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero.
Iwayama H; Hosono H; Yamamoto H; Oshiro M; Ueda N
Birth Defects Res A Clin Mol Teratol; 2007 Oct; 79(10):680-4. PubMed ID: 17803201
[TBL] [Abstract][Full Text] [Related]
11. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
Chattaway JM; Klepser TB
Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
[TBL] [Abstract][Full Text] [Related]
12. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
13. Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero.
Löllgen RM; Calza AM; Schwitzgebel VM; Pfister RE
J Pediatr Endocrinol Metab; 2011; 24(3-4):215-8. PubMed ID: 21648296
[TBL] [Abstract][Full Text] [Related]
14. Antithyroid drug therapy in pregnancy and risk of congenital anomalies: Systematic review and meta-analysis.
Agrawal M; Lewis S; Premawardhana L; Dayan CM; Taylor PN; Okosieme OE
Clin Endocrinol (Oxf); 2022 Jun; 96(6):857-868. PubMed ID: 34845757
[TBL] [Abstract][Full Text] [Related]
15. Congenital anomalies in children exposed to antithyroid drugs in-utero: a meta-analysis of cohort studies.
Li H; Zheng J; Luo J; Zeng R; Feng N; Zhu N; Feng Q
PLoS One; 2015; 10(5):e0126610. PubMed ID: 25974033
[TBL] [Abstract][Full Text] [Related]
16. Effects of methimazole and propylthiouracil exposure during pregnancy on the risk of neonatal congenital malformations: A meta-analysis.
Song R; Lin H; Chen Y; Zhang X; Feng W
PLoS One; 2017; 12(7):e0180108. PubMed ID: 28671971
[TBL] [Abstract][Full Text] [Related]
17. Management of hyperthyroidism during pregnancy and lactation.
Azizi F; Amouzegar A
Eur J Endocrinol; 2011 Jun; 164(6):871-6. PubMed ID: 21389085
[TBL] [Abstract][Full Text] [Related]
18. Treatment of hyperthyroidism in pregnancy and birth defects.
Clementi M; Di Gianantonio E; Cassina M; Leoncini E; Botto LD; Mastroiacovo P;
J Clin Endocrinol Metab; 2010 Nov; 95(11):E337-41. PubMed ID: 20668039
[TBL] [Abstract][Full Text] [Related]
19. Gestational thyrotoxicosis, antithyroid drug use and neonatal outcomes within an integrated healthcare delivery system.
Lo JC; Rivkees SA; Chandra M; Gonzalez JR; Korelitz JJ; Kuzniewicz MW
Thyroid; 2015 Jun; 25(6):698-705. PubMed ID: 25747892
[TBL] [Abstract][Full Text] [Related]
20. Toxicological considerations for antithyroid drugs in children.
Karras S; Tzotzas T; Krassas GE
Expert Opin Drug Metab Toxicol; 2011 Apr; 7(4):399-410. PubMed ID: 21323607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]